{"id":839,"date":"2021-01-12T16:45:00","date_gmt":"2021-01-12T16:45:00","guid":{"rendered":"https:\/\/funding.venturecenter.co.in\/news\/?p=839"},"modified":"2021-01-12T16:45:32","modified_gmt":"2021-01-12T16:45:32","slug":"birac-announces-request-for-expression-of-interest-reoi-under-mission-covid-suraksha-development-of-covid-19-vaccine-candidates-submission-deadline-15-jan-2021","status":"publish","type":"post","link":"https:\/\/funding.venturecenter.co.in\/news\/birac-announces-request-for-expression-of-interest-reoi-under-mission-covid-suraksha-development-of-covid-19-vaccine-candidates-submission-deadline-15-jan-2021\/","title":{"rendered":"BIRAC Announces Request for Expression Of Interest REOI under MISSION COVID SURAKSHA – Development of COVID-19 vaccine candidates Submission Deadline : 15 Jan 2021"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
BIRAC Announces Request for Expression Of Interest REOI under MISSION COVID SURAKSHA – Development of COVID-19 vaccine candidates<\/span><\/span><\/strong><\/div>\n
<\/div>\n
To ensure accelerated development of a vaccine for COVID-19, the objective of this REOI is to support Regulatory toxicology studies, manufacturing clinical trial material, and clinical development for licensure of COVID-19 vaccine candidates, and other activities to ensure accelerated development of vaccine candidates such that within the next 12 months they are closer to licensure and introduction in the market.<\/div>\n<\/div>\n
\n

The proposals can be submitted by any one of the following:<\/p>\n

    \n
  1. Company (Start-up, Small, Medium, or Large), LLP incorporated under the Companies Act, 2013, having a minimum of 51% of the shares of the Company to be held by Indian Citizens (Indian passport holders).<\/li>\n
  2. Academia (Public or Private Research Institute, University) having a well-established support system for research. The institute should have been established in India and have NAAC\/ UGC\/ AICTE or any equivalent recognition certificate or any other Public\/Government supported organization<\/li>\n
  3. Non-profit organizations\/ Society\/ Trusts\/ Foundation\/ Associations\/ Government entities\/ Institutes\/ R&D Organizations\/ which is a legal entity<\/li>\n<\/ol>\n

    Announcement Date:<\/b> 01-12-2020
    \nLast Submission Date:<\/b> 15-01-2021 05:00 PM<\/p>\n

    More on: https:\/\/birac.nic.in\/cfp_view.php?id=58&scheme_type=37<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

    \n
    \n
    \n
    <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    BIRAC Announces Request for Expression Of Interest REOI under MISSION COVID SURAKSHA – Development of COVID-19 vaccine candidates To ensure accelerated development of a vaccine for COVID-19, the objective of this REOI is to support Regulatory toxicology studies, manufacturing clinical trial material, and clinical development for licensure of COVID-19 vaccine candidates, and other activities to… Continue reading BIRAC Announces Request for Expression Of Interest REOI under MISSION COVID SURAKSHA – Development of COVID-19 vaccine candidates Submission Deadline : 15 Jan 2021<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-839","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts\/839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/comments?post=839"}],"version-history":[{"count":2,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts\/839\/revisions"}],"predecessor-version":[{"id":843,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts\/839\/revisions\/843"}],"wp:attachment":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/media?parent=839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/categories?post=839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/tags?post=839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}